NEW YORK--(BUSINESS WIRE)--
Pfizer Inc. today announced the election of Albert Bourla, DVM, Ph.D. to
its Board of Directors, effective immediately.
Dr. Bourla, age 56, is currently the Chief Operating Officer (COO) of
Pfizer. Prior to assuming the role of COO in 2018, he was the Group
President of Pfizer Innovative Health, responsible for the Consumer
Healthcare, Inflammation and Immunology, Internal Medicine, Oncology,
Rare Disease and Vaccines business groups.
Dr. Bourla joined Pfizer in 1993, and has held a number of senior global
positions in several markets across several disciplines, including:
Group President, Global Vaccines, Oncology and Consumer Healthcare
business; President and General Manager, Established Products; Area
President of Europe, Africa, Middle East, Asia and Pacific, Animal
Health; and Vice President, Business Development and New Products,
Animal Health.
Dr. Bourla is a doctor of Veterinary Medicine and holds a Ph.D. in
Biotechnology of Reproduction from the Veterinary School of Aristotle
University. He is a member of the Board of Directors of the Pfizer
Foundation and the Biotechnology Innovation Organization (BIO), where he
serves on the Executive Committee.
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring therapies
to people that extend and significantly improve their lives. We strive
to set the standard for quality, safety and value in the discovery,
development and manufacture of health care products. Our global
portfolio includes medicines and vaccines as well as many of the world's
best - known consumer health care products. Every day, Pfizer colleagues
work across developed and emerging markets to advance wellness,
prevention, treatments and cures that challenge the most feared diseases
of our time. Consistent with our responsibility as one of the world's
premier innovative biopharmaceutical companies, we collaborate with
health care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all who
rely on us. We routinely post information that may be important to
investors on our website at www.pfizer.com.
In addition, to learn more, please visit us on www.pfizer.com
and follow us on Twitter at @Pfizer
and @Pfizer_News,
LinkedIn,
YouTube
and like us on Facebook at Facebook.com/Pfizer.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180223005286/en/
Source: Pfizer Inc.